Tyra Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-7.8M | $-8.1M | $312.0K | $439.0K |
| FY2021 | $-23.7M | $-24.4M | $661.0K | $2.9M |
| FY2022 | $-50.3M | $-50.8M | $559.0K | $10.6M |
| FY2023 | $-50.1M | $-50.9M | $770.0K | $13.5M |
| FY2024 | $-69.8M | $-70.4M | $664.0K | $22.8M |